Patent Foramen Ovale Management for Secondary Stroke Prevention:State-of-the-Art Appraisal of Current Evidence
Stroke 55:236-247, Sposato,L.A.,et al, 2024
Thrombectomy for Anterior Circulation Stroke Beyond 6 h from Time Last Known Well (AURORA): A Systematic Review and Individual Patient Data Meta-Analysis
Lancet 399:249-258, Jovin, T.G.,et al, 2022
Endovascular Treatment in Older Adults with Acute Ischemic Stroke in the MR CLEAN Registry
Neurol 95:e131-e139, Groot, A.E.,et al, 2020
Cerebral Venous Thrombosis in Older Patients
Stroke 49:197-200, Zuurbier, S.M.,et al, 2018
Intracranial Atherosclerosis
Lancet 383:984-998, Qureshi, A. & Caplan, L.R., 2014
Safety of Thrombolysis in Patients Over the Age of 80
The Neuroogist 18:99-101, Willey,J.Z.,et al, 2012
Factors Influencing In-Hospital Delay in Treatment with Intravenous Thrombolysis
Stroke 43:1578-1583, Mikulik, R.,et al, 2012
Elderly Patients are at Higher Risk for Poor Outcomes after Intra-Arterial Therapy
Stroke 43:2356-2361, Chandra, R.V.,et al, 2012
Intravenous Thrombolysis in Nonagenarians With Ischemic Stroke
Stroke 42:1967-1970, Sarikaya, H.,et al, 2011
Intravenous thrombolysis in acute ischaemic stroke: a systematic review and meta-analysis to aid decision making in patients over 80 years of age
JNNP 82:712-717, Bhatnagar, P.,et al, 2011
Is Thrombolysis Safe in the Elderly? Analysis of a National Database
Stroke 41:2259-2264, Alshekhlee,A.,et al, 2010
Identifying Patients at High Risk for Poor Outcomes After Intra-Arterial Therapy for Acute Ischemic Stroke
Stroke 40:1780-1785, Hallevi,H.,et al, 2009
Intravenous Alteplase for Stroke: Beyond the Guidelines and in Particular Clinical Situations
Stroke 38:2612-2618, De Keyser,J.,et al, 2007
Patent Foramen Ovale and Cryptogenic Stroke in Older Patients
NEJM 357:2262-2268, Handke,M.,et al, 2007
Thrombolysis for Acute Stroke with Special Emphasis on the Very Old:Experience From a Single Dutch Centre
JNNP 77:375-377,288, van Oostenbrugge,R.J.,et al, 2006
Thrombolysis in Patients Older Than 80 Years With Acute Ischaemic Stroke: Canadian Alteplase for Stroke Effectiveness Study
JNNP 77:826-829,812, Sylaja, P.N.,et al, 2006
The Stroke-Thrombolytic Predictive Instrument: A Predictive Instrument for Intravenous Thrombolysis in Acute Ischemic Stroke
Stroke 37:2957-2962,2865, Kent,D.M.,et al, 2006
Intravenous rt-PA for Acute Stroke: Comparing Its Effectiveness in Younger and Older Patients
JNNP 76:1234-1237, Mouradian,M.S.,et al, 2005
Cerebral Vein and Dural Sinus Thrombosis in Elderly Patients
Stroke 36:1927-1932, Ferro,J.M.,et al, 2005
Outcome and Severe Hemorrhagic Complications of Intravenous Thrombolysis With Tissue Plasminogen Activator in Very Old (=80 Years) Stroke Patients
Stroke 36:2421-2425, Berrouschot,J.,et al, 2005
Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: No
Stroke 35:804-805,806, Tong,D.C. &Becker,K.J., 2004
Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: Yes
Stroke 35:803-804,806, Furlan,A.J., 2004
Age As a Determinant of Adverse Events in Medically Treated Cryptogenic Stroke Patients with Patent Foramen Ovale
Stroke 35:2145, Homma,S.,et al, 2004
Poor Outcome After First-Ever Stroke
Stroke 34:122-126, Appelros,P.,et al, 2003
Risk Factors for Sever Hemorrhagic Transformation in Ischemic Stroke Patients Treated with Recombinant Tissue Plasminogen Activator
Stroke 32:438-441, Larrue,V.,et al, 2001
Treatment with Tissue Plasminogen Activator and Inpatient Mortality Rates for Patients with Ischemic Stroke Treated in Community Hospitals
Stroke 32:1832-1839,1840, Reed,S.D.,et al, 2001
Clinical Features and Prognostic Factors of Cerebral Venous Sinus Thrombosis in a Prospective Series of 59 Patients
JNNP 70:105-108, de Bruijn,S.F.T.M.,et al, 2001
Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Patients Aged 80 Years and Older, The tPa Stroke Survey Experience
Stroke 31:370-375, Tanne,D.,et al, 2000
Intracranial Hemorrhage Associated With Thrombolytic Therapy for Eldery Patients With Acute Myocardial Infarction
Stroke 31:1802-1811, Brass,L.M. et al, 2000
Survival and Recurrence After First Cerebral Infarction, Study in Rochester, Minn, 1975-1989
Neurol 50:208-216, Petty,G.W.,et al, 1998
Warfarin Use Following Ischemic Stroke Among Medicare Patients with Atrial Fibrillation
Arch Int Med 158:2093-2100, Brass,L.A.,et al, 1998
Embolic Brain Infarction in Nonrheumatic Atrial Fibrillation
Neurol 48:1593-1597, Yamanouchi,H.,et al, 1997
Paroxysmal Atrial Fibrillation:High Frequency of Embolic Brain Infarction in Elderly Autopsy Patient
Neurol 49:1691-1694, Yamanouchi,H.,et al, 1997
Relationship of Cardiac Disease to Stroke Occurrence, Recurrence, and Mortality
Stroke 23:1250-1256, Broderick,J.P.,et al, 1992
A Prognostic System for Transient Ischemia or Minor Stroke
Ann Int Med 114:552-557, Kerman,W.N.,et al, 1991
Physicians'Attitudes Toward Anticoag & Antiplat Agents for Stroke Prevent in Elderly Pts with Atrial Fib
Arch Int Med 151:1950-1953, 19221991., Kutner,M.,et al, 1991
The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial Fibrillation
NEJM 323:1505-1511, 1556-15581990., Kistler,J.P.,et al, 1990
Hemorrhagic Transformation in Cerebral Embolism
Stroke 20:598-603, Okada,Y.,et al, 1989
Nonvalvular Atrial Fibrillation as a Cause of Fatal Massive Cerebral Infarction in the Elderly
Stroke 20:1653-1656, Yamanouchi,H.,et al, 1989
Herpes Zoster-Associated Encephalitis:Clinicopathologic Report of 12 Cases and Review of the Literature
Medicine 62:81-95, Jemsek,J.,et al, 1983